Basic Information
Basic information for LINC01821-211-14aa
Peptide Name LINC01821-211-14aa
Genome Position chr2:194369008-194369049[+]
Species Human
Peptide Sequence MPEELSDGKLINIK
Peptide Length 14
Unique No (LINC01821-201-14aa,LINC01821-202-14aa,LINC01821-203-14aa,LINC01821-204-14aa,LINC01821-205-14aa,LINC01821-206-14aa-1,LINC01821-207-14aa,LINC01821-208-14aa-2,LINC01821-209-14aa,LINC01821-210-14aa-1,LINC01821-214-14aa)
Grand Average of Hydropathicity -0.4357
Relative Molecular Mass 1821.04
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000225539;LINC01821
Transcript ID/Name ENST00000659759;LINC01821-211
Transcript Length 1974
Coding Ability 0.2548
DNA Sequence Corresponding to Peptide ATGCCAGAGGAACTTAGTGATGGCAAACTTATCAATATAAAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :